Recalls, Market Withdrawals, & Safety Alerts
The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this page. See Additional information about recalls for a more complete listing.
The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. To search archived content, visit Search FDA Archive and input the name of the product and/or company name in the Search terms box as well as the year to get the most inclusive search results. To scroll through archived Recalls, Market Withdrawals & Safety Alerts content by year, see the Recall and Safety Alerts Archive.
Sign up to receive Recalls, Market Withdrawals and Safety Alerts.* FDA Employees: Use Chrome to Subscribe until further notice.
| Date | Brand Name(s) | Product Description | Product Type | Recall Reason Description | Company Name | Terminated Recall | Excerpt |
|---|---|---|---|---|---|---|---|
| GSMS Inc. | Losartan potassium tablets | Drugs, Generic Drugs | Detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) | Teva Pharmaceuticals USA, Inc. | Terminated | … initiated on April 25, 2019 in the United States of losartan potassium tablets. This expanded recall includes six (6) lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength … | |
| Heritage | Losartan Potassium Tablets USP | Drugs | Due to the detection of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) | Vivimed | … Life Sciences Pvt Ltd (Vivimed) is recalling 19 lots of Losartan Potassium Tablets USP 25 mg, 50 mg, and 100 mg to consumer … any reports of adverse events related to this recall. Losartan Potassium is indicated for the treatment of … |